Related Funds
Funds with similar focus
Fund Name | Location |
Advanced Fibre Communications (AFC) | California, Petaluma, United States |
C&B Capital | Atlanta, Georgia, United States |
Cyber Agent Ventures | Beijing, Beijing, China |
Fair/e | France, Lyon, Rhone-Alpes |
Headway Ventures | De Pere, United States, Wisconsin |
Industrial Alliance Securities Inc | - |
JCMB Beteiligungs | Germany, Hamburg |
KeyPlayers | - |
Lorinvest | Brazil, Rio de Janeiro, Rio De Janeiro |
Monestier Capital | - |
Nexus Medical Partners | Massachusetts, Quincy, United States |
Pi Labs | England, London, United Kingdom |
TOHO GAS | Aichi Prefecture, Japan, Nagoya |
Tracxn labs | Bangalore, India, Karnataka |
Upstream Ventures | Central, Central Region, Singapore |
Variant Alternative Income Fund | - |
Warren Citrin Impact Seed Fund | - |
WuXi PharmaTech | China, Shanghai |
Your Voice SPA | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
OWL | $157M | 19 Mar 2024 | Bielefeld, Nordrhein-Westfalen, Germany | ||
Bicara Therapeutics | $108M | 06 Mar 2023 | Cambridge, Massachusetts, United States | ||
CARGO Therapeutics | $200M | 01 Mar 2023 | Palo Alto, California, United States | ||
Rondo Therapeutics | $67M | 02 Mar 2022 | Hayward, California, United States | ||
CARGO Therapeutics | 01 Jan 2022 | Palo Alto, California, United States | |||
Magnus Medical | $25M | 28 Oct 2021 | Burlingame, California, United States | ||
Acrigen Biosciences | 28 Sep 2021 | Berkeley, California, United States | |||
Ceribell | $53M | 29 Apr 2021 | Mountain View, California, United States | ||
Pipeline Therapeutics | $80M | 11 Feb 2021 | San Diego, California, United States |
– Magnus Medical, Inc. from Burlingame is developing non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.
– The company raised $25m in Series A funding.
– The round was co-led by Jazz Venture Partners and Red Tree Venture Capital.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
OWL | $157M | 19 Mar 2024 | Bielefeld, Nordrhein-Westfalen, Germany | ||
Bicara Therapeutics | $108M | 06 Mar 2023 | Cambridge, Massachusetts, United States | ||
CARGO Therapeutics | $200M | 01 Mar 2023 | Palo Alto, California, United States | ||
Rondo Therapeutics | $67M | 02 Mar 2022 | Hayward, California, United States | ||
CARGO Therapeutics | 01 Jan 2022 | Palo Alto, California, United States | |||
Magnus Medical | $25M | 28 Oct 2021 | Burlingame, California, United States | ||
Acrigen Biosciences | 28 Sep 2021 | Berkeley, California, United States | |||
Ceribell | $53M | 29 Apr 2021 | Mountain View, California, United States | ||
Pipeline Therapeutics | $80M | 11 Feb 2021 | San Diego, California, United States |